The impact of gut microbiota modulation on responses to immune checkpoint inhibitors in cancer.

The gut microbiota has emerged as a critical determinant of antitumor immunity and a potential modulator of responses to immune checkpoint inhibitors (ICIs). Although pre-clinical and clinical studies suggest that specific bacterial taxa may influenc…

Preview only. Read the full abstract at the source